Warfarin Telehealth Education
OtherPatients received education on warfarin through a video on an iPad, and were assessed on knowledge pre and post video, and at follow up visit
NCT Number: NCT03650777
The objective of this study is to evaluate the effectiveness of telehealth warfarin education in a charity outpatient clinic. The purpose is to increase patient knowledge with regard to their warfarin therapy and to measure knowledge retention
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
a. This study is a prospective, single-centered, randomized controlled quality improvement pilot study.
a. Setting: a pharmacy b. Description: A pharmacist will provide education about warfarin using not only verbal instructions but also provide illustrations of directions. Please refer to Appendix for dialogue.
a. Patients' INR will be taken and warfarin education will be given verbally similar to Monday-Thursday clinic. A written brochure will be given.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients received education on warfarin through a video on an iPad, and were assessed on knowledge pre and post video, and at follow up visit
Time frame: pre and post video test(20 minutes)
Difference in pre warfarin education video and post video test for warfarin education in patients receiving warfarin education via iPad
Time frame: initial and follow up visit (max 30 days)
Difference in pre video test and follow up retention test for warfarin education in patients receiving warfarin education via iPad
Time frame: Between initial and follow up visit ( max 30 days)
Descriptive results of patient self reported adherence (yes/no response) related to warfarin between initial and follow up visit
Time frame: Max 30 days
A satisfaction survey (designed by pharmacy resident) with 4 questions based on Likert scale (0-5), and one free response question patient completes on follow up visit. Name of Scale used for 4 questions: Likert. (Range 1-5, 1= highly disagree, 2= disagree, 3-neutral, 4-agree, 5-highly agree). There was no total of scoring, each response was individual of each other.
Time frame: Between initial and follow up visit ( max 30 days)
Descriptive results of patient self reported adverse events related to warfarin between initial and follow up visit
Time frame: Between initial and follow up visit ( max 30 days)
Time patient was within therapeutic range for their INR goal between initial and follow up visit
Baylor Research Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07617415
Educational Problems, Nurse's Role
Gümüşhane, Turkey (Türkiye)
View Trial DetailsNCT06319989
Educational Problems
Gainesville, Florida, United States
View Trial DetailsNCT06777641
Educational Problems
Taipei, Taiwan
View Trial DetailsNCT06639633
Anatomical Pathological Condition, Educational Problems
Bolu, Merkez, Turkey (Türkiye)
View Trial Details